Radiation treatment monitoring with DCE-US in CWR22 prostate tumor xenografts.

Conclusion DCE-US has been shown to detect vascular changes at a very early stage after radiotherapy, which is a great advantage since DCE-US is non-invasive, available at most hospitals, and is low in cost compared to other techniques used in clinical practice.
PMID: 30231620 [PubMed - as supplied by publisher]

Source: Acta Radiologica - September 19, 2018 Category: Radiology Authors: Arteaga-Marrero N, Mainou-Gomez JF, Brekke Rygh C, Lutay N, Roehrich D, Reed RK, Olsen DR Tags: Acta Radiol Source Type: research